(Q46843858)

25 December 2017

title

Cost utility of prenatal diagnosis and the risk-based threshold (English)

1 reference

25 December 2017

author name string

Ryan A Harris

1 reference

25 December 2017

A Eugene Washington

1 reference

25 December 2017

Robert F Nease

1 reference

25 December 2017

Miriam Kuppermann

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

363

1 reference

25 December 2017

issue

9405

1 reference

25 December 2017

page(s)

276-282

1 reference

25 December 2017

Preventing the birth of infants with Down's syndrome: a cost-benefit analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Prenatal diagnosis--why is 35 a magic number?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Decision analysis of prenatal testing for chromosomal disorders: what do the preferences of pregnant women tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Economic evaluation of prenatal diagnosis: a methodological review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Economic evaluation of prenatal screening for Down syndrome in the U.S.A.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Down syndrome serum marker screening: decision criteria and implicit values

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Current Maternal Age Recommendations for Prenatal Diagnosis: A Reappraisal Using the Expected Utility Theory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Chromosomal abnormality rates at amniocentesis and in live-born infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Low fetal loss rates after ultrasound-proved viability in early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Final report.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Randomised controlled trial of genetic amniocentesis in 4606 low-risk women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Reproductive behaviour following spontaneous loss of pregnancy after prenatal diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Reproductive behaviour and prenatal diagnosis following genetic termination of pregnancy in women of advanced maternal age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Pregnancy termination because of chromosomal abnormalities: a study of 26,950 amniocenteses in the southeast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Risk evaluation of CVS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Accuracy of cytogenetic findings on Chorionic Villus Sampling (CVS)—diagnostic consequences of CVS Mosaicism and non-Mosaic Discrepancy in Centres contributing to EUCROMIC 1986–1992

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

Methodological limitations of economic evaluations of antenatal screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915385-8

7 January 2021

10.1016/S0140-6736(03)15385-8

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017